Cargando…
Meta-analysis of the prognostic value of long non-coding RNA PVT1 for cancer patients
BACKGROUND: Plasmacytoma variant translocation 1 (PVT1) is reported to be dysregulated in various cancers. Therefore, this meta-analysis was performed to clarify its utility as a prognosis marker in malignant tumors. METHODS: Electronic databases, including PubMed, OVID, Cochrane Library, and Web of...
Autores principales: | Ma, Chao, Nie, Xing-Guo, Wang, Yan-Li, Wu, Da-Peng, Liang, Qiu-dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310588/ https://www.ncbi.nlm.nih.gov/pubmed/30544468 http://dx.doi.org/10.1097/MD.0000000000013548 |
Ejemplares similares
-
Prognostic value of long non-coding RNA PVT1 as a novel biomarker in various cancers: a meta-analysis
por: Zhu, Shikai, et al.
Publicado: (2017) -
PVT1 Long Non-coding RNA in Gastrointestinal Cancer
por: Martínez-Barriocanal, Águeda, et al.
Publicado: (2020) -
Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer
por: Boloix, Ariadna, et al.
Publicado: (2019) -
Prognostic Value of lncRNA PVT1 for Patients with Gastric Cancer: A Meta-Analysis
por: Hao, Jinyong, et al.
Publicado: (2021) -
Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer
por: Yao, Weiping, et al.
Publicado: (2022)